(1)

Second primary malignancies (SPMs) in patients with non-pulmonary well-differentiated neuroendocrine tumours (wdNETs)

ea0060p04 | (1)

A case series of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

ea0060p05 | (1)

Problematic bronchial carcinoid

ea0060p06 | (1)

Identifying information and support needs for patients with Merkel Cell Carcinoma

ea0060p07 | (1)

Bone metastases (BMs) in patients with neuroendocrine neoplasms (NENs): Prevalence and clinical management in a tertiary cancer centre

ea0060p08 | (1)

Periodic endoscopic surveillance in patients with low risk type I gastric neuroendocrine tumours (gNETs) also detects associated gastric adenocarcinoma in a subset of patients

ea0060p09 | (1)

Lesson learnt: severe skin reaction to somatostatin analogue injections

ea0060p10 | (1)

Everolimus – associated grade 4 pneumonitis: a case report and literature discussion

ea0060p11 | (1)

Circulating neuroendocrine tumor gene expression is effective in monitoring peptide receptor radionuclide (PRRT) efficacy

ea0060p15 | (1)

NETest liquid biopsy is diagnostic of lung neuroendocrine tumors and identifies progressive disease

ea0060p16 | (1)

Validation of the NETest liquid biopsy as a diagnostic for gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

ea0060p17 | (1)

Use of choline PET-CT in the diagnosis of neuroendocrine tumours

ea0060p18 | (1)

The impact of ⁶⁸Ga-based PET-CT scanning on the management of patients with sporadic pancreatic neuroendocrine tumours (pNETs)

ea0060p19 | (1)

Imaging in paragangliomas and phaeochromocytomas: a pictorial review

ea0060p20 | (1)

Chest metastases in advanced small bowel neuroendocrine neoplasms: incidence and outcome

ea0060p21 | (1)

Utility of PRRT therapy in invasive intra-cardiac paraganglioma

ea0060p23 | (1)

Seeking the unseen: a case of occult sporadic insulinoma: localization, surgical strategy: a rare case

ea0060p24 | (1)

Assessment of fat-soluble vitamins and trace elements in neuroendocrine tumour (NET) patients on somatostatin analogues

ea0060p26 | (1)

Tumour growth rate (TGR) in neuroendocrine tumours (NETs): changes following systemic treatment and external validation of previous findings; the GREPONET-2 study

ea0060p27 | (1)

Unmasking ectopic ACTH secretion and changing functionality of a pulmonary neuroendocrine tumour with carcinoid syndrome

ea0060p28 | (1)

Bronchial carcinoid presenting in young adults. A case series highlighting issues in disease management, unusual sites of metastases and long term surveillance

ea0060p29 | (1)

The role of imaging in neuroendocrine tumours

ea0060p30 | (1)

Endocrine Abstracts

UKI NETS 16th National Conference

Poster Presentations

Functional or non-function pancreatic NET; Novel use of a flash glucose monitoring system

Overview of neuroendocrine patient demographics and outcomes in the Leicestershire region

Second primary malignancies (SPMs) in patients with non-pulmonary well-differentiated neuroendocrine tumours (wdNETs)

A case series of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

Problematic bronchial carcinoid

Identifying information and support needs for patients with Merkel Cell Carcinoma

Bone metastases (BMs) in patients with neuroendocrine neoplasms (NENs): Prevalence and clinical management in a tertiary cancer centre

Periodic endoscopic surveillance in patients with low risk type I gastric neuroendocrine tumours (gNETs) also detects associated gastric adenocarcinoma in a subset of patients

Lesson learnt: severe skin reaction to somatostatin analogue injections

Everolimus – associated grade 4 pneumonitis: a case report and literature discussion

Nutritional status of patients at diagnosis with a bronchial NET

Glenfield Pulmonary Neuroendocrine Guidelines

Automated finger prick genomic diagnosis of neuroendocrine tumors

Circulating neuroendocrine tumor gene expression is effective in monitoring peptide receptor radionuclide (PRRT) efficacy

NETest liquid biopsy is diagnostic of lung neuroendocrine tumors and identifies progressive disease

Validation of the NETest liquid biopsy as a diagnostic for gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Use of choline PET-CT in the diagnosis of neuroendocrine tumours

The impact of ⁶⁸Ga-based PET-CT scanning on the management of patients with sporadic pancreatic neuroendocrine tumours (pNETs)

Imaging in paragangliomas and phaeochromocytomas: a pictorial review

Chest metastases in advanced small bowel neuroendocrine neoplasms: incidence and outcome

Utility of PRRT therapy in invasive intra-cardiac paraganglioma

Seeking the unseen: a case of occult sporadic insulinoma: localization, surgical strategy: a rare case

Assessment of fat-soluble vitamins and trace elements in neuroendocrine tumour (NET) patients on somatostatin analogues

Tumour growth rate (TGR) in neuroendocrine tumours (NETs): changes following systemic treatment and external validation of previous findings; the GREPONET-2 study

Unmasking ectopic ACTH secretion and changing functionality of a pulmonary neuroendocrine tumour with carcinoid syndrome

Bronchial carcinoid presenting in young adults. A case series highlighting issues in disease management, unusual sites of metastases and long term surveillance

The role of imaging in neuroendocrine tumours

The impact of ⁶⁸Ga-based PET-CT scanning on the management of patients with familial pancreatic neuroendocrine tumours (panNETs)

BiosciAbstracts